Saudi Arabia Zika Virus Testing Market
完整報告名稱與涵蓋範圍
Saudi Arabia Zika Virus Testing Market Size, Share & Trends Analysis Report By Test Type (ELISA-based Tests, Molecular Diagnostic Kits), By Product (Consumables, Instruments), By End-use (Hospitals, Diagnostic Laboratories), And Segment Forecasts, 2026 - 2033
報告摘要
Saudi Arabia Zika Virus Testing Market Summary
The Saudi Arabia zika virus testing market size was valued at USD 150.34 thousand in 2025 and is projected to grow from USD 156.01 thousand in 2026 to USD 200.25 thousand by 2033, at a CAGR of 3.63% from 2026 to 2033. Market growth is mainly due to rising international travel and pilgrimage activity, which increases the risk of imported cases, while asymptomatic infections make early detection difficult.
In addition, favorable climatic conditions and growing vector surveillance activities are increasing awareness and demand for Zika diagnostic testing.
Saudi Arabia Zika Virus Testing Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the Saudi Arabia zika virus testing market report based on test type, product, and end-use:
• Test Type (Revenue, USD Thousands, 2021 - 2033)
o ELISA-Based Tests
o Molecular Diagnostic Kits
o Rapid Diagnostic Tests (RDTs)
o Lateral Flow Assays (Antigen-Based)
• Product Outlook (Revenue, USD Thousands, 2021 - 2033)
o Consumables
o Instruments
o Others
• End-use Outlook (Revenue, USD Thousands, 2021 - 2033)
o Hospitals
o Diagnostic Laboratories
o Government & Public Health Laboratories
o Research Institutes
授權報價
| Single User License | $5,950 USD |
| Enterprise License | $6,950 USD |
| Corporate User License | $8,950 USD |
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Test Type Segment
1.1.1.2. Product Segment
1.1.1.3. End Use Segment
1.2. Estimates and Forecast Timeline
1.2.1. Objectives
1.2.2. Objective - 1
1.2.3. Objective - 2
1.2.4. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Test Type & Product Snapshot
2.3. End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of zika cases and mosquito-borne diseases
3.2.1.2. Government initiatives and expansion of healthcare infrastructure
3.2.1.3. Growing adoption of advanced diagnostic technologies
3.2.2. Market Restraint Analysis
3.2.2.1. High costs of advanced diagnostic technologies
3.2.2.2. Limited awareness and underdiagnosis in certain countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Test Type Business Analysis
4.1. Saudi Arabia Zika Virus Testing Market: Test Type Movement Analysis
4.2. ELISA-Based Tests
4.2.1. ELISA-based Tests Market, 2021 - 2033 (USD Thousands)
4.3. Molecular Diagnostic Kits
4.3.1. Molecular Diagnostic Kits Market, 2021 - 2033 (USD Thousands)
4.4. Rapid Diagnostic Tests (RDTs)
4.4.1. Rapid Diagnostic Tests (RDTs) Market, 2021 - 2033 (USD Thousands)
4.5. Lateral Flow Assays (Antigen-Based)
4.5.1. Lateral Flow Assays (Antigen-based) Market, 2021 - 2033 (USD Thousands)
Chapter 5. Product Business Analysis
5.1. Saudi Arabia Zika Virus Testing Market: Product Movement Analysis
5.2. Consumables
5.2.1. Consumables Market, 2021 - 2033 (USD Thousands)
5.3. Instruments
5.3.1. Instruments Market, 2021 - 2033 (USD Thousands)
5.4. Others
5.4.1. Others Market, 2021 - 2033 (USD Thousands)
Chapter 6. End Use Business Analysis
6.1. Hospitals
6.1.1. Hospitals Market, 2021 - 2033 (USD Thousands)
6.2. Diagnostic Laboratories
6.2.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Thousands)
6.3. Government & Public Health Laboratories
6.3.1. Government & Public Health Laboratories Market, 2021 - 2033 (USD Thousands)
6.4. Research Institutes
6.4.1. Research Institutes Market, 2021 - 2033 (USD Thousands)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2022
7.4. Company Profiles/Listing
7.4.1. Abbott
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Technology Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. F. Hoffmann-La Roche Ltd
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Technology Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Thermo Fisher Scientific, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Technology Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Bio-Rad Laboratories, Inc.
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Technology Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. SD Biosensor
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Technology Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. QuidelOrtho Corporation
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Technology Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. InBios International, Inc.
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Technology Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. CTK Biotech, Inc.
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Technology Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. GENBODY INC.
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Technology Benchmarking
7.4.9.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1 List of abbreviation
Table 2 Saudi Arabia zika virus testing market, by test type, 2021 - 2033 (USD Thousands)
Table 3 Saudi Arabia zika virus testing market, by product, 2021 - 2033 (USD Thousands)
Table 4 Saudi Arabia zika virus testing market, by end use, 2021 - 2033 (USD Thousands)
List of Figures
Fig. 1 Saudi Arabia zika virus testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Test type and product segment snapshot
Fig. 11 End use segment snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 In Vitro Diagnostics (IVD) market value, 2023 (USD Thousands)
Fig. 14 Market trends & outlook
Fig. 15 Porter’s five force analysis
Fig. 16 PESTEL analysis
Fig. 17 Saudi Arabia zika virus testing market: Test type outlook and key takeaways
Fig. 18 Saudi Arabia zika virus testing market: Test type movement analysis
Fig. 19 ELISA-based tests market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 20 Molecular diagnostic kits market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 21 Rapid diagnostic tests (RDTs) market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 22 Lateral flow assays (antigen-based) market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 23 Saudi Arabia zika virus testing market: Product outlook and key takeaways
Fig. 24 Saudi Arabia zika virus testing market: Product movement analysis
Fig. 25 Consumables market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 26 Instruments market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 27 Others market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 28 Saudi Arabia zika virus testing market: End use outlook and key takeaways
Fig. 29 Saudi Arabia zika virus testing market: End use movement analysis
Fig. 30 Hospitals market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 31 Diagnostic laboratories market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 32 Government & public health laboratories market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 33 Research institutes market estimates and forecast, 2021 - 2033 (USD Thousands)
Fig. 34 Key company categorization
Fig. 35 Company market share analysis, 2025
Fig. 36 Strategic framework
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們